Dry Powder Inhaler Market Insights, Forecast to 2025

23
Dry Powder Inhaler Market

dry-powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus. DPIs are an alternative to the aerosol-based inhalers commonly called metered-dose inhaler (or MDI).

Chronic obstructive pulmonary disease will continue to be the fast-expanding application of dry powder inhalers.

The Dry Powder Inhaler market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dry Powder Inhaler.

Report Sample includes:
– Table of Contents
– List of Tables & Figures
– Charts
– Research Methodology

Get FREE Sample of Dry Powder Inhaler Market Report

 

This report presents the worldwide Dry Powder Inhaler market size (value, production and consumption), splits the breakdown (data status 2014-2019 and forecast to 2025), by manufacturers, region, type and application.

This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

The following manufacturers are covered in this report:

  • Astrazeneca
  • 3M
  • GlaxoSmithKline
  • Novartis
  • Cipla
  • Teva
  • Boehringer Ingelheim
  • Chiesi Farmaceutici
  • MannKind
  • Vectura

Dry Powder Inhaler Breakdown Data by Type

  • Single Dose Dry Powder Inhaler
  • Multi Dose Dry Powder Inhaler

Dry Powder Inhaler Breakdown Data by Application

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Others

Dry Powder Inhaler Production by Region

  • United States
  • Europe
  • China
  • Japan
  • Other Regions

Dry Powder Inhaler Consumption by Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Rest of Europe
  • Central & South America
  • Brazil
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides:

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: help@24marketreports.com

Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports